CDC data show rising GLP-1 use as part of diabetes therapy, reflecting guideline adoption
Schedule a virtual visit, and after your consultation, well conveniently ship your medication directly to your doorstep
Body Mass Index (BMI) Criteria: BMI 30 kg/m: Patients with a BMI of 30 or higher (classified as obese) are eligible for Semaglutide treatment
If nausea remains problematic despite conservative management strategies, healthcare providers may consider maintaining a lower dose for an extended period before further escalation, or in some cases, temporarily reducing the dose
"You can call it a 'wonder drug' that it's been very, very helpful for people - more so than the past other medications that have been around," Dr
This is part of the weight loss process